IEEE Trans Nanobioscience. 2023 Jul;22(3):562-569. doi: 10.1109/TNB.2022.3219104. Epub 2023 Jun 29.
A surface plasmon resonance (SPR) refractometric sensor based on gold (Au) and titanium dioxide (TiO) coated Photonic Crystal Fiber (PCF) is presented for the quick detection of various types of cancerous cells. The cancerous cells and their corresponding normal cells are both considered to be liquid cells each with their unique refractive index (RI). Normally these cells are found in liquid form in the suitable media (food) required to live the cancerous/normal cell lines. Also in our detection case, liquid samples are easy to pump into the sensing channel of the proposed PCF by employing either pressure or capillary forces.The proposed PCF sensor works on the SPR principle, with the Au coating serving as the plasmonic material. This sensor is investigated using the COMSOL Multiphysics software computational tool that is based on the full-vector finite element method (FEM). A TiO coating has been applied to enhance adhesion between the Au layer and the PCF surface. Above the Au coating, cancerous cells samples are filled into the PCF. When the core mode of the PCF is coupled with the surface plasmon polariton (SPP) mode under the specific resonance circumstances, SPR will occur on the interface of the gold-sample cell, and in the core mode, the loss peak is observed at the resonance wavelength. Cancerous cells samples have a distinct loss peak than normal cells samples therefore the cancerous cells can be diagnosed by measuring the shift in resonance wavelength corresponding to the loss peak of cancerous and their normal cells samples. The proposed sensor may identify various cancerous cells such as MDAMB-231, MCF-7, PC12, HeLa, and Jurkat for the diagnosis of breast cancer type-1, breast cancer type-2, adrenal glands, cervical, and blood cancer respectively. The computed wavelengths sensitivities of the proposed PCF are 9428.57nm/RIU, 10714.28nm/RIU, 7571.43nm/RIU, 5500nm/RIU, and 6000nm/RIU for the MDAMB-231, MCF-7, PC12, HeLa, and Jurkat cancerous cells, respectively. However, for various cancerous cells, the maximum amplitude sensitivity varies from -1387 RIU to -1599 RIU. Moreover, the sensor resolution ranges between 0.93 ×10 RIU and 1.82 ×10 RIU with a 0.024 maximum detection limit. Because of its improved sensing capability, the presented SPR refractometric sensor is appropriate for the early detection of cancerous cells.
一种基于金(Au)和二氧化钛(TiO)涂层光子晶体光纤(PCF)的表面等离子体共振(SPR)折射传感器,用于快速检测各种类型的癌细胞。癌细胞和相应的正常细胞都被认为是具有独特折射率(RI)的液体细胞。通常,这些细胞在适合生存的合适介质(食物)中以液体形式存在,癌细胞/正常细胞系。同样在我们的检测案例中,通过使用压力或毛细作用力,液体样品很容易被泵入所提出的 PCF 的传感通道中。所提出的 PCF 传感器基于 SPR 原理工作,金涂层用作等离子体材料。该传感器使用基于完全矢量有限元方法(FEM)的 COMSOL Multiphysics 软件计算工具进行研究。已经施加了 TiO 涂层以增强 Au 层与 PCF 表面之间的附着力。在 Au 涂层上方,充满癌细胞样品的 PCF。当 PCF 的芯模在特定共振情况下与表面等离子体激元(SPP)模耦合时,SPR 将在金-样品细胞界面上发生,并且在芯模中,在共振波长处观察到损耗峰。癌细胞样品的损耗峰明显高于正常细胞样品,因此可以通过测量对应于癌细胞和正常细胞样品的损耗峰的共振波长的位移来诊断癌细胞。所提出的传感器可以识别各种癌细胞,如 MDAMB-231、MCF-7、PC12、Hela 和 Jurkat,分别用于诊断乳腺癌 1 型、乳腺癌 2 型、肾上腺、宫颈和血液癌。所提出的 PCF 的计算波长灵敏度分别为 9428.57nm/RIU、10714.28nm/RIU、7571.43nm/RIU、5500nm/RIU 和 6000nm/RIU,用于 MDAMB-231、MCF-7、PC12、Hela 和 Jurkat 癌细胞。然而,对于各种癌细胞,最大幅度灵敏度在-1387 RIU 到-1599 RIU 之间变化。此外,传感器分辨率在 0.93×10 RIU 和 1.82×10 RIU 之间,最大检测极限为 0.024。由于其改进的传感能力,所提出的 SPR 折射传感器适用于癌细胞的早期检测。